The
International Conference on Harmonization is an unique
effort to register the pharmaceuticals for human use all over the world. International Conference On Harmonization intends to bring together the regulatory authorities of Europe, Japan and the United States and all the experts from the pharmaceutical industry in the three regions with the aim to discuss scientific and technical aspects of product registration.
Policies are discussed at the
International Conference On Harmonization with the intention of achieving greater harmonization in the interpretation and applications of technical guidelines. The main objective of such International Conference On Harmonization is to obviate the need to duplicate the testing ,which is carried out during the research and development of new medicines.
The International Conference On Harmonization assures the eradication of any kind of un- necessary delay in the development and availability of new medicines but at the same time it guarantees the quality, efficacy, and safety of public health.
Broadly,the International Conference On Harmonization has three main purposes:
- The International Conference On Harmonization acts as a forum for a dialog exchange between regulatory authorities and the pharmaceutical industries regarding the technical requirements for product registration.
- The International Conference On Harmonization also aims to detect the areas where technical modifications are required.
- The International Conference On Harmonization also recommends practical ways of achieving greater harmonization
